Diabetes mellitus is currently considered an important public health problem due to an increase in its prevalence. The disease and its chronic micro-and macrovascular complications cause high direct and indirect costs, impairing productivity and quality of life and resulting in higher morbidity and mortality rates. The prevalence of diabetes mellitus has been increasing in developed and developing countries. In Brazil, data from the multicenter study about diabetes mellitus have shown a 7.6% prevalence of the disease in the population aged 30 to 69 years, and in the year 2010 an approximate diabetic population of 11 million people is estimated to exist in the country, representing a 100% increase compared with the current diabetic population of 5 million people 1 . The high morbidity and mortality of patients with diabetes mellitus depends on the chronic complications, which involve several tissues, impairing the micro-and macrovasculature. In fact, diabetes mellitus contributes to most cases of terminal renal disease in the Western world, and is also the major cause of acquired blindness and of diseaserelated amputations of the lower limbs. After the discovery of insulin in 1921, cardiovascular diseases became the major cause of morbidity and mortality in diabetic individuals 2 . According to the Framingham study 3 , over 50% of the mortality in diabetic patients relates to cardiovascular diseases, and the incidence of cerebrovascular and coronary artery diseases is 2-to 4-times greater in diabetic patients than in the general population. In addition, the diabetic patients developing cardiovascular diseases have a poorer prognosis and greater mortality 4-7 . Currently, a series of evidence indicates that the physiopathogeny of the vascular disease in diabetes mellitus is associated with endothelial dysfunction. Studies about the presence of endothelial dysfunction in diabetic patients have been controversial, which may be attributed to differences in the methods used for its detection 8 . On the other hand, most experimental studies have shown changes in the endothelial physiology induced by elevated concentrations of glucose, although these concentrations were extremely 
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The high morbidity and mortality of patients with diabetes mellitus depends on the chronic complications, which involve several tissues, impairing the micro-and macrovasculature. In fact, diabetes mellitus contributes to most cases of terminal renal disease in the Western world, and is also the major cause of acquired blindness and of diseaserelated amputations of the lower limbs. After the discovery of insulin in 1921, cardiovascular diseases became the major cause of morbidity and mortality in diabetic individuals 2 . According to the Framingham study 3 , over 50% of the mortality in diabetic patients relates to cardiovascular diseases, and the incidence of cerebrovascular and coronary artery diseases is 2-to 4-times greater in diabetic patients than in the general population. In addition, the diabetic patients developing cardiovascular diseases have a poorer prognosis and greater mortality [4] [5] [6] [7] . Currently, a series of evidence indicates that the physiopathogeny of the vascular disease in diabetes mellitus is associated with endothelial dysfunction. Studies about the presence of endothelial dysfunction in diabetic patients have been controversial, which may be attributed to differences in the methods used for its detection 8 . On the other hand, most experimental studies have shown changes in the endothelial physiology induced by elevated concentrations of glucose, although these concentrations were extremely 1 6 2 1 6 2 1 6 2 1 6 2 high compared with the glucose levels frequently found in the management of diabetic patients . The present study aimed at assessing the acute effects of the high concentrations of glucose routinely found in diabetic patients in daily clinical practice on the reactivity of the renal microcirculation of nondiabetic rabbits.
Methods
New Zealand albinistic rabbits were anesthetized with sodium pentobarbital (40 mg/kg, I.V.), immobilized with pancuronium bromide (1 mg/kg, I.V.) to allow mechanically controlled ventilation, and received heparin (500 IU/kg, I.V.). After a median laparotomy, both kidneys were isolated and the renal arteries and veins were catheterized. Then, the kidney was placed in a Petri dish and the renal artery was perfused with the nutrient Krebs-Henseleit solution gassed with carbogenium (95% O 2 -5% CO 2 ) at a constant flow (4 mL/ min) for later measurement of the perfusion pressure. After inducing precontraction of the renal circulation with continuous perfusion of noradrenalin (10 µM), dose-response curves were recorded for assessing the vasodilating effect of the 2 following substances: acetylcholine (endotheliumdependent vasodilation) and sodium nitroprusside (endothelium-independent vasodilation). The perfusion line was connected to a pressure transducer (7016 model, Ugo Basile, Comerio, Italy) and the modifications in the perfusion pressure were continuously measured and then recorded on a 2-channel polygraph recorder (Gemini 7070, Ugo Basile, Comerio, Italy). The composition of the Krebs-Henseleit solution used was (in mM): 118 NaCl, 4.7 KCl, 1.17 MgSO 4 , 2.5 CaCl 2 6H 2 O, 1.2 NaH 2 PO 4 , 25 NaHCO 3 , 5.5 glucose, and 0.25% bovine serum albumin (pH 7.4).
The rabbit renal circulation was perfused with different concentrations of glucose solutions for 3 hours. Two groups were formed as follows: one receiving a physiological concentration of glucose (5.5 mM, control group) and another receiving a high concentration of glucose (15 mM), which corresponded to the mean postprandial glycemia of a certain population of diabetic patients followed up at the outpatient care unit for diabetes of the Hospital Universitá-rio Pedro Ernesto of the Universidade do Estado do Rio de Janeiro. After perfusion, submaximal precontraction (80% of the maximal response) of the renal circulation was induced through continuous infusion of noradrenaline (10 µM), and, then, increasing doses of acetylcholine (10 -7 -10 -5 mol) were administered in the line for renal perfusion to determine the endothelium-dependent vasodilating responses.
The same protocol described was used to assess the endothelium-independent vasodilating response. Sodium nitroprusside (0.1-2.5 mg), a substance that donates nitric oxide and whose vasodilating effect does not depend on the integrity of the vascular endothelium was administered in the line for renal perfusion to record the dose-response curves.
The renal circulation was perfused for 3 hours with solutions with the same osmolarity of the high concentration glucose solution (15 mM). For this, mannitol was added to the 5.5 mM glucose solution. After perfusion, submaximal precontraction (80% of the maximal response) of the renal circulation was induced through continuous infusion of noradrenaline (10 µM), and increasing doses of acetylcholine (10 -7 -10 -5 mol) were administered in the line for renal perfusion to record the dose-response curve.
The drugs used were as follows: acetylcholine chloride, (±)-arterenol hydrochloride (noradrenaline), sodium nitroprusside, mannitol, D-glucose, sodium pentobarbital (Sigma Chemical Co., St. Louis, MO, USA), and pancuronium bromide (Pancuron, Cristália, Brazil).
The results were shown as mean ± MSE for each group. Determination of the significant differences between the groups was performed with analysis of variance (ANOVA). When a significant difference was detected with ANOVA, the Student-Newman-Keuls test was used to locate the significant differences. Differences with a P value lower than 0.05 were considered significant. The statistical calculations were performed with Graphpad Instat (Graphpad Software, London University, England) software. Figure 1 illustrates the effects of the perfusion with a high concentration glucose (15mM) solution on endothelium-dependent vasodilation. The relaxation induced by acetylcholine was significantly lower in the group perfused with a 15 mM glucose solution compared with that in the control group (P < 0.05), and a maximal reduction of 24.5± 3% in the perfusion pressure was reached compared with the maximal reduction of 41±4% in the control group. Figure 2 shows the effects of different concentrations of glucose on endothelium-independent vasodilation. No significant differences between the control (5.5 mM) and the high glucose (15 mM) groups were observed. Figure 3 shows the effects of hyperosmolarity (15 mM mannitol) on endothelium-mediated vasodilation. A nonsignificant reduction in acetylcholine-induced relaxation occurred compared with that in the control group, except for the dose of 10 -5 mol, in which a significantly lower reduction in the perfusion pressure occurred in the 15 mM mannitol group. The maximal reduction in the perfusion pressure in the 15 mM mannitol group was 30±3% compared with 41±4% in the control group.
Results

Discussion
It has been established that the endothelium plays critical roles in homeostasis in the body, because it can secrete several chemical mediators and interact with vascular smooth muscle cells and with elements present in the circulation, such as the hematopoietic cells. The major endothelial functions are as follows: 1) control of the vascular tonus through the secretion of vasoactive substances; 2) regulation of the growth of vascular smooth muscle cells; 3) participation in inflammatory reactions; and 4) hemostasia 31, 32 . It is not surprising that several factors, such as smoking, systemic arterial hypertension, dyslipidemia, hyperhomocysteinemia, and hyperglycemia itself, implicated in the pathogeny of vasculopathies have in common the presence of perturbations in endothelial physiology. In diabetic patients, a complex interaction of factors, such as hyperglycemia, systemic arterial hypertension, dyslipidemia, and hyperinsulinemia/insulin resistance, causing endothelial dysfunction usually exists mainly in type 2 diabetes 8, 33 . In type 1 diabetes, the major agent seems to be hyperglycemia 8, 33 , which proved to be an important factor for microvascular complications in patients with type 1 diabetes mellitus in the DCCT 34 (Diabetes Control and Complications Trial) and Steno 35 studies and in type 2 diabetic patients as reported in the UKPDS 36 (United Kingdom Prospective Diabetes Study). Hyperglycemia may also play a role in the pathogenesis of macrovascular complications 37, 38 . One of the major vasoactive mediators released by the endothelial cell is nitric oxide, which has several antiatherogenic effects, such as a reduction in platelet aggregation, inhibition of the secretion of growth factors and molecules of endothelial adhesion, and stimulation of the inhibitor of the κB nuclear transcription factor, IκBα 8, 33 . Several experimental studies and studies in human beings with diabetes mellitus have shown a reduction in endothelial nitric oxide, which may be attributed to several causes. Hyperglycemia has a set of mechanisms that potentially reduces endothelial nitric oxide, including the reduction in the activity of nitric oxide synthase due to depletion of NADPH. The latter is caused by the activation in the polyol route, the activation of PKC, and the increase in oxidative stress, leading to inactivation of nitric oxide with formation of nitrite peroxide 8 . It is the current consensus to consider that endothelial dysfunction may contribute both to microangiopathy and macroangiopathy of diabetes mellitus 8, 33 . The endothelial cell has multiple functions, and no singular definition of endothelial dysfunction exists 8 . The various definitions found in the studies range from functional alterations, mainly the capacity of vasodilation induced by substances or by maneuvers that stimulate the secretion of nitric oxide by the endothelium, to changes in the amount of chemical mediators produced by the endothelial cell. In that context, endothelial dysfunction has been typically defined as a reduction in the vasodilating response to acetylcholine (or to metacholin) or to reactive hyperemia, which causes the release of nitric oxide by the endothelium. The determination of the levels of substances derived from the endothelium, such as endothelin, thrombomodulin, and the von Willebrand factor, should also be carefully interpreted, because their alterations may reflect changes in the synthesis or breakdown of these mediators 8, 33 . Functional studies in diabetic patients have reported conflicting results 8 . Several obstacles, from ethical to methodological, have made these studies difficult. The most reliable method of assessing blood flow in human beings, which is measurement with an intravascular catheter, is invasive, expensive, risky for the patient, and performed only in a few research centers 8 . In general, the cost, subjectivity, and absence of validation have challenged the reliability of other functional methods. Some studies, such as that by Johnstone et al 39 , assessing the reactivity of vessels of resistance in the forearm of type 1 diabetic patients, reported a reduction in the vasodilating response to acetylcholine compared with that in the control group, while the vasodilating responses to sodium nitroprusside and to verapamil were similar in both groups. On the other hand, Smiths et al 40 and Halkin et al 41 found no reduction in endothelium-dependent vasodilation in type 1 diabetic patients.
The most different methodologies concerning the evaluation of the presence of alterations in endothelial function caused by glucose have been applied in experimental studies. In this regard, in vivo studies with diabetic animals 9 , studies with isolated organs (for example: aortic rings) of diabetic animals [10] [11] [12] [13] [14] [15] , with isolated organs of nondiabetic animals exposed to high concentrations of glucose for a certain period of time [16] [17] [18] [19] [20] , and with cultures of endothelial cells exposed to a medium with high concentrations of glucose exist [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [42] [43] [44] . Several studies did not include control with osmotic substances, but with nonabsorbable substances metabolized by the cell (ex: mannitol) 21, 27, 28 . This generated doubts about whether the alterations found were specifically due to glucose or hyperosmolarity of the medium. Our study showed that hyperosmolarity can cause a reduction in endothelium-dependent vasodilation, although the latter was significant only in the highest dose of acetylcholine and had lower intensity compared with the reduction caused by the 15 mM glucose concentration. In addition, the glucose concentrations used in the various studies were very high compared with those routinely found in clinical practice . On the contrary, in our study, we found the presence of acute endothelial dysfunction in concentrations similar to those routinely found in diabetic patients, mainly in the postprandial period, confirming the importance of postprandial glycemic levels in the pathogenesis of the chronic complications of the disease. Recently, the DECODE Study 45 (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe) reported that postprandial hyperglycemia was the best predictor of mortality in type 2 diabetic patients. We also emphasize that, so far, most studies have been performed in conductance vessels (macrovasculature), and the literature about the alterations in reactivity of the microcirculation mediated by glucose is scarce. We studied a structure whose damage from diabetes mellitus is well known: the renal microcirculation. And we observed that high levels of glucose can interfere with the normal endothelial physiology in microcirculation.
In conclusion, high levels of glucose similar to those found in diabetic patients in the postprandial period can cause acute significant alterations in the endothelium of the renal microcirculation in nondiabetic rabbits. These effects may also occur in diabetic patients and, in the long run, may contribute to the physiopathogeny of the vascular disease of diabetes mellitus. 
